1Miller W H jr. Molercular targets of arsenic trioxide in malignant cells. Oncologist. 2002, 7:14-19.
2Chen G Q, Zhu J, Shi X G. et al. In vitro studies on cellular and molecular promyelocytic leukemia = AS2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR cdpha/PML proteins. Blood. 1996, 88:1052-1061.
3Terstappen L W. Hollander Z, Mciners H L. et al.Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol,1990, 48:138-148.
4Chen G Q, Shi X G, Tang W, et al. Use of arsenic trioxide (AS2O3)in the treatment of acute promyelocytic leukemia (APL), I: AS2O3 exerts dose-dependent dual effects on APL cells. Blood. 1997, 89:3345-3353.
5Chen G Q, Zhu J. Shi X G, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide(AS2O3) in the treatment of acute promyclocytic leukemia: AS2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood, 1996, 88:1052-1061.
6Ling Y, Dai J. Chalmers-Redman R M, et al. Arsenic trioxide selectively induces acute promyelocytic leukeia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood. 1999, 94:2102-2111.
7Shao W, Fanelli M, Ferrara F F. et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARαlpha protein in acute promyclocytic leukemia cells. J Nall Cancer Inst. 1998. 90:124-133.
8Wang Z G, Ruggcro D, Roncheui S. ctal. PML is essential for multiple apoptotic pathways. Nat Genet,1998, 20:266-272.
9Guo A. Salomoni P, Luo J. et al. The function of PML in P53-dependent apoptsis. Nat Cell Biol, 2000. 2:730-736.
10Quignon F, De Bcls F, Kokon M. et al. PML induces a novel caspase-independent death process. Nat Genet,1998, 20:259-265.
